Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
Clinical trial NCT01682876 · COMPLETED
Trial details
- NCT number
- NCT01682876
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-07
- Primary completion
- 2013-07-02
- Enrollment
- 715
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.